Journal of Autoimmunity

Article	Citations
The 2022 outbreak and the pathobiology of the monkeypox virus	320
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19	230
Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses	210
Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies	178
Complement activation and endothelial perturbation parallel COVID-19 severity and activity	127
Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection	123
Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy	106
Ferritin – from iron, through inflammation and autoimmunity, to COVID-19	102
COVID-19 convalescent plasma composition and immunological effects in severe patients	95
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups	91
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination	89
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?	78
Autoimmune hepatitis after COVID-19 vaccine – more than a coincidence	75
Auto-immune hepatitis following COVID vaccination	72
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature	69
Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial	68
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients	68
Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies	67
A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination	67
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19	59
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review	58
Lupus nephritis: new progress in diagnosis and treatment	58
Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?	57
Marginal zone B cells: From housekeeping function to autoimmunity?	55
Resistant starch intake alleviates collagen-induced arthritis in mice by modulating gut microbiota and promoting concomitant propionate production	55

Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab	53
Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data	52
Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis	51
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases	48
The complement system and human autoimmune diseases	47
Perspectives on vaccine induced thrombotic thrombocytopenia	47
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data	47
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target	47
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development	47
Regulatory T cells in autoimmune hepatitis: an updated overview	46
New developments implicating IL-21 in autoimmune disease	46
Mushrooms and immunity	45
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study	44
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19	44
Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus	43
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study	42
High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients	42
Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications	42
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers	41
Intestinal permeability in type 1 diabetes: An updated comprehensive overview	40
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination	39
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals	38
Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p	38
Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study	37
Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines	37
Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome	37
Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation	35
Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis	34
Relapsed and newly diagnosed Graves’ disease due to immunization against COVID-19: A case series and review of the literature	33
A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score	33
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy	32
Pathogenesis, multi-omics research, and clinical treatment of psoriasis	32
Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreak	32
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19	31
Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities	30
Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?	30
Autoimmune dysautonomia in women with silicone breast implants	30
Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients	29
Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications	29
Early diagnosis and treatment for Sjögren's syndrome: current challenges, redefined disease stages and future prospects	27
Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status	27
Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis	27
Transcriptome landscape of double negative T cells by single-cell RNA sequencing	26
Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair follicle	26
Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression	26
T follicular helper cells in autoimmune diseases	26
Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis	25
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network	25
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort	25
Gut microbiota in systemic lupus erythematosus: A fuse and a solution	25

T helper cell immunity in pregnancy and influence on autoimmune disease progression	25
A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center	24
Fecal microbiota transplantation: Emerging applications in autoimmune diseases	24
Molecular mimicry and autoimmunity in the time of COVID-19	23
Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica	23
Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases	23
Neutrophil-derived extracellular vesicles induce endothelial inflammation and damage through the transfer of miRNAs	23
Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4+ and CD8+ T-cell clusters in systemic sclerosis	23
Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis	23
Autophagy pathways in autoimmune diseases	22
Pre-existing conditions associated with post-acute sequelae of COVID-19	22
Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways	22
Infectious diseases, autoantibodies, and autoimmunity	21
Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production	21
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis	21
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review	21
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients	21
B cell-targeted therapies in systemic lupus erythematosus	21
Telomeres: New players in immune-mediated inflammatory diseases?	21
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study	20
Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment	20
Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong	20
Interferon signature in giant cell arteritis aortitis	19
Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis	19
Rituximab plus belimumab in non-infectious refractory cryoglobulinemia vasculitis: A pilot study	19
Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases	18
Research progress of single-cell transcriptome sequencing in autoimmune diseases and autoinflammatory disease: A review	18
Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14hi monocytes	18
The gut ecosystem and immune tolerance	18
Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis	18
Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark	17
Advances in SLE classification criteria	17
Immune recognition of lysyl-tRNA synthetase and isoleucyl-tRNA synthetase by anti-OJ antibody-positive sera	17
A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine	17
HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes	17
Autoreactive T cells and their role in atopic dermatitis	16
Involvement of trained immunity during autoimmune responses	16
Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines	16
Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application	16
Influence of X chromosome in sex-biased autoimmune diseases	16
Flagellin-specific human CAR Tregs for immune regulation in IBD	16
Skin CD4+ Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases	15
Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis	15
ETS-1 facilitates Th1 cell-mediated mucosal inflammation in inflammatory bowel diseases through upregulating CIRBP	15
Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases	15
Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus	15
Novel autoantibodies to the β-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes	15
Enhanced type I interferon signature induces neutrophil extracellular traps enriched in mitochondrial DNA in adult-onset Still's disease	15
Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis	15
Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus	15
Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases	15
Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study	14
Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer	14
Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes	14
Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus	14
Alterations in corneal biomechanics underlie early stages of autoimmune-mediated dry eye disease	14
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function	14
Cognitive dysfunction in SLE: An understudied clinical manifestation	14
Engineered Treg cells: The heir to the throne of immunotherapy	13
Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus	13
Thrombocytopenia after COVID-19 vaccination	13
Identification of a primary antigenic target of epitope spreading in endemic pemphigus foliaceus	13
Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight	13
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis	13
Screening patients with autoimmune endocrine disorders for cytokine autoantibodies reveals monogenic immune deficiencies	13
A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves’ disease mouse model	13
Autoimmune hepatitis following COVID-19 vaccination	13
Age-related bone diseases: Role of inflammaging	12
Genomic instability in early systemic sclerosis	12
Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination	12
New insights into the taxonomy of autoimmune diseases based on polyautoimmunity	12
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations	12
A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells	12
RNA-binding protein hnRNP UL1 binds κB sites to attenuate NF-κB-mediated inflammation	12
Single-cell analysis highlights a population of Th17-polarized CD4+ naïve T cells showing IL6/JAK3/STAT3 activation in pediatric severe aplastic anemia	12
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING)	12
Fecal microbiota transplantation for the management of autoimmune diseases: Potential mechanisms and challenges	11
Sex-specific analysis in Behçet's disease reveals higher genetic risk in male patients	11
UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus	11
Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease	11

mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency	11
Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications	11
Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases	11
A Guillain-Barré syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides	11
Nuclear translocation of RIG-I promotes cellular apoptosis	11
Immune-mediated enteropathies: From bench to bedside	11
Recent advances in cutaneous lupus	11
Antigen-specific immune reactions by expanded CD8+ T cell clones from HLA-B*27-positive patients with spondyloarthritis	11
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome	11
Th1-like Treg in vitiligo: An incompetent regulator in immune tolerance	11
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial	11
zVAD alleviates experimental autoimmune hepatitis in mice by increasing the sensitivity of macrophage to TNFR1-dependent necroptosis	11
The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis	11
Pregnancy-related complications in systemic lupus erythematosus	11
Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis	10
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases	10
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy	10
Impaired dynamic X-chromosome inactivation maintenance in T cells is a feature of spontaneous murine SLE that is exacerbated in female-biased models	10
Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression	10
Peripheral monocytes and soluble biomarkers in autoimmune encephalitis	10
IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes	10
Tissue-specific activation of Myd88-dependent pathways governs disease severity in primary Sjögren's syndrome	10
Interferon (IFN)-stimulated gene 15: A novel biomarker for lymphoma development in Sjögren's syndrome	10
The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model	10
The landscape of T and B lymphocytes interaction and synergistic effects of Th1 and Th2 type response in the involved tissue of IgG4-RD revealed by single cell transcriptome analysis	10
COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study	10
A single-cell map of peripheral alterations after FMT treatment in patients with systemic lupus erythematosus	9
Epidemiology of granulomatosis with polyangiitis and microscopic polyangiitis in adults in France	9
Tissue-resident memory T cells: The key frontier in local synovitis memory of rheumatoid arthritis	9
Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations	9
IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis	9
Transcriptomic profiling of iris tissue highlights LCK signaling and T cell-mediated immunity in Behcet's uveitis	9
Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis	9
Autoimmunity to neuroretina in the concurrent absence of IFN-γ and IL-17A is mediated by a GM-CSF-driven eosinophilic inflammation	9
Gut microbial signatures and their functions in Behcet's uveitis and Vogt-Koyanagi-Harada disease	9
Cutaneous involvement in anti-HMGCR positive necrotizing myopathy	9
The role of faecal microbiota transplantation in chronic noncommunicable disorders	9
Autoantibodies targeting malondialdehyde-modifications in rheumatoid arthritis regulate osteoclasts via inducing glycolysis and lipid biosynthesis	9
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells	9
Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome	9
Forced Fox-P3 expression can improve the safety and antigen-specific function of engineered regulatory T cells	9
T cell aging as a risk factor for autoimmunity	9
Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population	9
Gluten-free diet reduces autoimmune diabetes mellitus in mice across multiple generations in a microbiota-independent manner	9
Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?	9
GILZ regulates type I interferon release and sequesters STAT1	9
Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination	8
Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases	8
COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases	8
Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors	8
Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner	8
MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A	8
Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2	8
Genetic association and differential expression of HLA Complex Group lncRNAs in pemphigus	8
Compositional and functional aberrance of the gut microbiota in treatment naïve patients with primary Sjögren's syndrome [J. Autoimmun., 134, January 2023, 102958]	8
Post COVID-19 hospitalizations in patients with chronic inflammatory diseases – A nationwide cohort study	8
The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of pathogenic CD4+ T helper cell responses	8
The amino acid variants in HLA II molecules explain the major association with adult-onset Still's disease in the Han Chinese population	8
Conformational state of C-reactive protein is critical for reducing immune complex-triggered type I interferon response: Implications for pathogenic mechanisms in autoimmune diseases imprinted by type	8
Salivary gland epithelial cell in Sjögren's syndrome: Metabolic shift and altered mitochondrial morphology toward an innate immune cell function	8
Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis	8
Autoreactive memory Th17 cells are principally derived from T-bet+RORγt+ Th17/1 effectors	8
NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity	8
rs9459874 and rs1012656 in CCR6/FGFR1OP confer susceptibility to primary biliary cholangitis	8
Individual functions of the histone acetyl transferases CBP and p300 in regulating the inflammatory response of synovial fibroblasts	7
Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review	7
Generation of self-reactive, shared T-cell receptor α chains in the human thymus	7
A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus	7
Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk	7
Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice	7
Risk for uveitis relapse after COVID-19 vaccination	7
Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases	7
Dual B-cell targeting therapy ameliorates autoimmune cholangitis	7
Mucosal-associated invariant T cells in Giant Cell Arteritis	7
Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls	7
Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity?	7
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis	7
Notch signaling dependent monocyte conversion alleviates immune-mediated neuropathies by regulating RBP-J/NR4A1 axis	7
Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren's model	7
Antigenic mimicry – The key to autoimmunity in immune privileged organs	7
Sonic hedgehog promotes synovial inflammation and articular damage through p38 mitogen-activated protein kinase signaling in experimental arthritis	7
Intrarenal synthesis of complement C3 localized to distinct vascular compartments in ANCA-associated renal vasculitis	7
SB431542 alleviates lupus nephritis by regulating B cells and inhibiting the TLR9/TGFβ1/PDGFB signaling	6
Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage	6
CD8 follicular T cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties	6
Chronic inflammation in high-fat diet-fed mice: Unveiling the early pathogenic connection between liver and adipose tissue	6
hsa-miR-424–5p and hsa-miR-513c-3p dysregulation mediated by IFN-γ is associated with salivary gland dysfunction in Sjögren's syndrome patients	6
CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus	6
Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease	6
CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis	6
Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus	6
Circulating T cells in sarcoidosis have an aberrantly activated phenotype that correlates with disease outcome	6
Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE	6
Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients	6
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases	6